The novel therapy of this peptide represents a significant development in the care of type 2 diabetes. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide909743.affiliatblogger.com/94529029/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment